title: Nivolumab induced radiation recall pneumonitis after two years of radiotherapy.
authors.affiliation: Third Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.
authors.forename: R
authors.initials: R
authors.lastname: Shibaki
authors.affiliation: Third Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Akamatsu
authors.affiliation: Department of Diagnostic Pathology, Wakayama Medical University, Wakayama City, Wakayama, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Fujimoto
authors.affiliation: Third Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Koh
authors.affiliation: Third Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.
authors.forename: N
authors.initials: N
authors.lastname: Yamamoto
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D008297:Male; D018307:Neoplasms, Squamous Cell / Q000188:drug therapy / Q000532:radiotherapy; D000077594:Nivolumab; D017564:Radiation Pneumonitis / Q000139:chemically induced / Q000209:etiology*
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D000077594:Nivolumab